Education
About Us
Working with TipRanks
Follow Us
Prenetics Group (PRE)
NASDAQ:PRE
PRE Stock Chart & Stats
$15.83
-$0.22(-3.97%)
At close: 4:00 PM EST
$15.83
-$0.22(-3.97%)
Day’s Range― - ―
52-Week Range$3.09 - $18.48
Previous CloseN/A
Volume5.03K
Average Volume (3M)138.91K
Market Cap
$221.74M
Enterprise Value$163.10M
Total Cash (Recent Filing)$27.71M
Total Debt (Recent Filing)$2.57M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Mar 17, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding12,524,823
10 Day Avg. Volume156,144
30 Day Avg. Volume138,906
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.43
Price to Sales (P/S)2.41
P/FCF Ratio-2.46
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue3.06
Enterprise Value/Gross Profit7.26
Enterprise Value/Ebitda-2.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Prenetics Group News
PRE FAQ
What was Prenetics Group’s price range in the past 12 months?
Prenetics Group lowest stock price was $3.09 and its highest was $18.48 in the past 12 months.
What is Prenetics Group’s market cap?
Prenetics Group’s market cap is $221.74M.
When is Prenetics Group’s upcoming earnings report date?
Prenetics Group’s upcoming earnings report date is Mar 17, 2026 which is in 59 days.
How were Prenetics Group’s earnings last quarter?
Prenetics Group released its earnings results on Nov 12, 2025. The company reported -$0.41 earnings per share for the quarter, beating the consensus estimate of -$0.55 by $0.14.
Is Prenetics Group overvalued?
According to Wall Street analysts Prenetics Group’s price is currently Overvalued.
Does Prenetics Group pay dividends?
Prenetics Group pays a Quarterly dividend of $0.7 which represents an annual dividend yield of N/A. See more information on Prenetics Group dividends here
What is Prenetics Group’s EPS estimate?
Prenetics Group’s EPS estimate is 0.04.
How many shares outstanding does Prenetics Group have?
Prenetics Group has 12,524,823 shares outstanding.
What happened to Prenetics Group’s price movement after its last earnings report?
Prenetics Group reported an EPS of -$0.41 in its last earnings report, beating expectations of -$0.55. Following the earnings report the stock price went up 7.27%.
Which hedge fund is a major shareholder of Prenetics Group?
Currently, no hedge funds are holding shares in PRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Prenetics Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
PRE Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
225.59%
12-Months-Change
Fundamentals
Return on Equity
-23.93%
Trailing 12-Months
Asset Growth
-16.65%
Trailing 12-Months
Company Description
Prenetics Group
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRE Earnings Call
Q3 2025
0:00 / 0:00
Technical Analysis
Ownership Overview
―
Insiders
0.05% Mutual Funds
6.33% Other Institutional Investors
93.45% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---